The Farnesoid X Receptor Modulates Adiposity and Peripheral Insulin Sensitivity in Mice*

The farnesoid X receptor (FXR) is a bile acid (BA)-activated nuclear receptor that plays a major role in the regulation of BA and lipid metabolism. Recently, several studies have suggested a potential role of FXR in the control of hepatic carbohydrate metabolism, but its contribution to the maintenance of peripheral glucose homeostasis remains to be established. FXR-deficient mice display decreased adipose tissue mass, lower serum leptin concentrations, and elevated plasma free fatty acid levels. Glucose and insulin tolerance tests revealed that FXR deficiency is associated with impaired glucose tolerance and insulin resistance. Moreover, whole-body glucose disposal during a hyperinsulinemic euglycemic clamp is decreased in FXR-deficient mice. In parallel, FXR deficiency alters distal insulin signaling, as reflected by decreased insulin-dependent Akt phosphorylation in both white adipose tissue and skeletal muscle. Whereas FXR is not expressed in skeletal muscle, it was detected at a low level in white adipose tissue in vivo and induced during adipocyte differentiation in vitro. Moreover, mouse embryonic fibroblasts derived from FXR-deficient mice displayed impaired adipocyte differentiation, identifying a direct role for FXR in adipocyte function. Treatment of differentiated 3T3-L1 adipocytes with the FXR-specific synthetic agonist GW4064 enhanced insulin signaling and insulin-stimulated glucose uptake. Finally, treatment with GW4064 improved insulin resistance in genetically obese ob/ob mice in vivo. Although the underlying molecular mechanisms remain to be unraveled, these results clearly identify a novel role of FXR in the regulation of peripheral insulin sensitivity and adipocyte function. This unexpected function of FXR opens new perspectives for the treatment of type 2 diabetes.

[1]  P. Cohen,et al.  Characterization of a 3-phosphoinositide-dependent protein kinase which phosphorylates and activates protein kinase Bα , 1997, Current Biology.

[2]  J. Olefsky,et al.  Protein Phosphatase 2A Negatively Regulates Insulin's Metabolic Signaling Pathway by Inhibiting Akt (Protein Kinase B) Activity in 3T3-L1 Adipocytes , 2004, Molecular and Cellular Biology.

[3]  L. Moore,et al.  Identification of a chemical tool for the orphan nuclear receptor FXR. , 2000, Journal of medicinal chemistry.

[4]  G. Shulman,et al.  On Diabetes: Insulin Resistance Cellular Mechanisms of Insulin Resistance , 2022 .

[5]  Heidi R. Kast-Woelbern,et al.  Natural Structural Variants of the Nuclear Receptor Farnesoid X Receptor Affect Transcriptional Activation* , 2003, The Journal of Biological Chemistry.

[6]  G. Shulman,et al.  Mechanism by Which Fatty Acids Inhibit Insulin Activation of Insulin Receptor Substrate-1 (IRS-1)-associated Phosphatidylinositol 3-Kinase Activity in Muscle* , 2002, The Journal of Biological Chemistry.

[7]  F. Liu,et al.  Mouse 3-Phosphoinositide-dependent Protein Kinase-1 Undergoes Dimerization and trans-Phosphorylation in the Activation Loop* , 2003, Journal of Biological Chemistry.

[8]  G. Shulman,et al.  Tissue-specific overexpression of lipoprotein lipase causes tissue-specific insulin resistance , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[9]  B. Hemmings,et al.  Advances in protein kinase B signalling: AKTion on multiple fronts. , 2004, Trends in biochemical sciences.

[10]  B. Staels,et al.  Farnesoid X receptor: a new player in glucose metabolism? , 2005, Endocrinology.

[11]  M. Czech,et al.  PTEN, but Not SHIP2, Suppresses Insulin Signaling through the Phosphatidylinositol 3-Kinase/Akt Pathway in 3T3-L1 Adipocytes* , 2005, Journal of Biological Chemistry.

[12]  E. Van Obberghen,et al.  SOCS-3 Is an Insulin-induced Negative Regulator of Insulin Signaling* , 2000, The Journal of Biological Chemistry.

[13]  Folkert Kuipers,et al.  The Farnesoid X Receptor Modulates Hepatic Carbohydrate Metabolism during the Fasting-Refeeding Transition* , 2005, Journal of Biological Chemistry.

[14]  J. Flier,et al.  Adipose Tissue as an Endocrine Organ , 2014 .

[15]  M. Birnbaum,et al.  Role of Akt/protein kinase B in metabolism , 2002, Trends in Endocrinology & Metabolism.

[16]  Grace Guo,et al.  The Farnesoid X-receptor Is an Essential Regulator of Cholesterol Homeostasis* , 2003, The Journal of Biological Chemistry.

[17]  D. Bernlohr,et al.  Expression of specific mRNAs during adipose differentiation: identification of an mRNA encoding a homologue of myelin P2 protein. , 1984, Proceedings of the National Academy of Sciences of the United States of America.

[18]  T. V. van Dijk,et al.  Quantification of hepatic carbohydrate metabolism in conscious mice using serial blood and urine spots. , 2003, Analytical biochemistry.

[19]  R. Ulrich,et al.  Reduction of protein tyrosine phosphatase 1B increases insulin-dependent signaling in ob/ob mice. , 2003, Diabetes.

[20]  I. Schulman,et al.  Regulation of Complement C3 Expression by the Bile Acid Receptor FXR* , 2005, Journal of Biological Chemistry.

[21]  R. Hammer,et al.  Insulin resistance and diabetes mellitus in transgenic mice expressing nuclear SREBP-1c in adipose tissue: model for congenital generalized lipodystrophy. , 1998, Genes & development.

[22]  R. Zechner,et al.  Severe hypertriglyceridemia, reduced high density lipoprotein, and neonatal death in lipoprotein lipase knockout mice. Mild hypertriglyceridemia with impaired very low density lipoprotein clearance in heterozygotes. , 1995, The Journal of clinical investigation.

[23]  Giovanni Galli,et al.  Coordinated Control of Cholesterol Catabolism to Bile Acids and of Gluconeogenesis via a Novel Mechanism of Transcription Regulation Linked to the Fasted-to-fed Cycle* , 2003, Journal of Biological Chemistry.

[24]  P. Edwards,et al.  Peroxisome proliferator-activated receptor-γ coactivator 1α (PGC-1α) regulates triglyceride metabolism by activation of the nuclear receptor FXR , 2004 .

[25]  B. Staels,et al.  The Farnesoid X Receptor (FXR) as Modulator of Bile Acid Metabolism , 2004, Reviews in Endocrine and Metabolic Disorders.

[26]  A. Grefhorst,et al.  Transient impairment of the adaptive response to fasting in FXR‐deficient mice , 2005, FEBS letters.

[27]  R. Savkur,et al.  Regulation of carbohydrate metabolism by the farnesoid X receptor. , 2005, Endocrinology.

[28]  F. Kuipers,et al.  Enterohepatic Circulation of Bile Salts in Farnesoid X Receptor-deficient Mice , 2003, Journal of Biological Chemistry.

[29]  P. Puigserver,et al.  Transcriptional regulation of adipogenesis. , 2000, Genes & development.

[30]  Masahiro Tohkin,et al.  Targeted Disruption of the Nuclear Receptor FXR/BAR Impairs Bile Acid and Lipid Homeostasis , 2000, Cell.

[31]  J. Holloszy,et al.  A potential link between muscle peroxisome proliferator- activated receptor-alpha signaling and obesity-related diabetes. , 2005, Cell metabolism.

[32]  S. Akira,et al.  Defective adipocyte differentiation in mice lacking the C/EBPβ and/or C/EBPδ gene , 1997 .

[33]  A. Fukamizu,et al.  Bile Acids Regulate Gluconeogenic Gene Expression via Small Heterodimer Partner-mediated Repression of Hepatocyte Nuclear Factor 4 and Foxo1* , 2004, Journal of Biological Chemistry.

[34]  B. Staels,et al.  Glucose regulates the expression of the farnesoid X receptor in liver. , 2004, Diabetes.

[35]  P. Young,et al.  Generation of multiple farnesoid-X-receptor isoforms through the use of alternative promoters. , 2002, Gene.